|
related topics |
{product, liability, claim} |
{product, candidate, development} |
{customer, product, revenue} |
{personnel, key, retain} |
{operation, international, foreign} |
{property, intellectual, protect} |
{acquisition, growth, future} |
|
Our future growth is dependent upon the development of new products, which requires significant research and development, clinical trials and regulatory approval, and therefore may not result in commercially viable products.
Failure to successfully select, negotiate and integrate acquired technologies, products or businesses could adversely affect our business.
We are subject to widespread government regulation which may delay the approval of our products or result in the recall of previously approved products.
Cost containment pressures and legislative or regulatory reforms may decrease the demand for our products and the prices that customers are willing to pay for our products.
Since we derive a significant portion of our revenues from international operations, changes in international economic or regulatory conditions could have a material impact on the results of our operations.
Reduction or interruption in supply of components and materials used to manufacture our products, resulting from events such as damage to any of our manufacturing facilities or the loss of any of our sole-source suppliers, and the inability to develop alternative sources of supply, could impair our ability to meet sales demand and adversely affect our manufacturing operations and related product sales.
A loss of key personnel or our inability to attract and retain additional personnel may adversely affect our business.
If we are unable to protect our intellectual property successfully our business could be adversely affected.
Full 10-K form ▸
|
|
related documents |
27096--9/13/2006--DATASCOPE_CORP |
8146--4/16/2008--ASTRO_MED_INC_/NEW/ |
10456--2/26/2008--BAXTER_INTERNATIONAL_INC |
9892--2/27/2007--BARD_C_R_INC_/NJ/ |
9892--2/23/2006--BARD_C_R_INC_/NJ/ |
9892--2/26/2008--BARD_C_R_INC_/NJ/ |
10456--3/7/2006--BAXTER_INTERNATIONAL_INC |
911649--4/2/2007--STRATEGIC_DIAGNOSTICS_INC/DE/ |
911649--3/31/2006--STRATEGIC_DIAGNOSTICS_INC/DE/ |
8146--4/16/2007--ASTRO_MED_INC_/NEW/ |
9892--2/26/2009--BARD_C_R_INC_/NJ/ |
55242--8/16/2007--KENNAMETAL_INC |
1114200--2/27/2008--AMERICAN_MEDICAL_SYSTEMS_HOLDINGS_INC |
16732--10/11/2006--CAMPBELL_SOUP_CO |
57528--2/22/2008--LANCE_INC |
764579--3/19/2008--CAS_MEDICAL_SYSTEMS_INC |
768408--6/28/2006--CYANOTECH_CORP |
768408--6/24/2010--CYANOTECH_CORP |
780127--1/12/2006--SYNOVIS_LIFE_TECHNOLOGIES__INC |
350692--12/28/2007--DELPHAX_TECHNOLOGIES_INC |
887497--7/14/2006--HI_TECH_PHARMACAL_CO_INC |
96943--2/25/2009--TELEFLEX_INC |
806517--3/27/2009--PSYCHEMEDICS_CORP |
277509--2/27/2008--FEDERAL_SIGNAL_CORP_/DE/ |
77597--1/14/2010--SPARTECH_CORP |
1101026--5/18/2009--HEALTH_ENHANCEMENT_PRODUCTS_INC |
7536--2/8/2008--ARROW_ELECTRONICS_INC |
1282543--3/30/2010--AFFIRMATIVE_INSURANCE_HOLDINGS_INC |
718924--12/28/2007--SPAN_AMERICA_MEDICAL_SYSTEMS_INC |
1032863--3/16/2007--FORCE_PROTECTION_INC |
|